Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing

被引：1

作者：

Cheo, S. W. ^{[1
]}

Zhao, J. J. ^{[1
,2
,3
,4
]}

Ong, P. Y. ^{[1
]}

Ow, S. G. W. ^{[1
]}

Ow, C. J. L. ^{[5
]}

Chan, G. H. J. ^{[1
]}

Walsh, R. J. ^{[1
]}

Lim, J. S. J. ^{[1
,2
,5
]}

Lim, S. E. ^{[1
]}

Lim, Y. W. ^{[1
]}

Wong, A. L. A. ^{[1
]}

Wong, J. e. -l. ^{[1
]}

Lee, S. C. ^{[1
,2
,5
]}

机构：

[1] Natl Univ Canc Inst, Dept Haematol Oncol, 1E Kent Ridge Rd, Singapore 119228, Singapore

[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore

[3] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore

[4] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore

[5] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore

来源：

ESMO OPEN | 2025年 / 10卷 / 03期

基金：

英国医学研究理事会;

关键词：

multiple primary cancers; pathogenic germline variants; germline genetic testing; extended testing; hereditary cancer predisposition syndrome; BREAST-CANCER; RISK; WOMEN; PREVALENCE; TUMORS;

D O I：

10.1016/j.esmoop.2025.104495

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Multiple primary cancers (MPC) are an indicator of potential hereditary cancer predisposition syndrome. There remains insufficient data on genetic testing outcomes and the optimal testing panel for MPC. We evaluated the prevalence of MPC, the spectrum of pathogenic germline variants (PGVs) and the role of extended panel testing in MPC. Methods: Cancer patients seen in a cancer genetics clinic in a tertiary cancer centre in Singapore from 2000 to 2023 were included. Clinical characteristics, PGV and patterns of cancer were analysed. Most patients were tested with 49 genes, but in a selected 156 patients with MPC, extended testing with 216 genes was carried out. Results: Of 3514 cancer patients (male = 17.9%, female = 82.1%), 668 (19%) had MPC (2 primaries, n = 570; 3 primaries, n = 81; >= 4 primaries, n = 17). The most common tumour pairs were breast-breast (33.2%), breast-ovary (8.9%), breast-endometrial (4.6%) and endometrial-ovary (4.6%). Patients with MPC had a younger median age of first cancer. Of the MPC patients, 29.4% tested positive for at least one PGV, with PGVs detected in BRCA1/2 (39.9%), other homologous recombination repair (HRR) genes (18.9%), mismatch repair (MMR) genes (11.2%) and TP53 (7%) genes. HRR genes included ATM, BARD1, BRIP1, CHEK2, PALB2, FANCL, RAD51C and RAD51D, while MMR genes included MLH1, MSH2, MSH6 and PMS2. MPC patients were more likely to have PGVs in TP53 and BARD1 compared with patients with single primary cancer. Extended testing detected more PGVs in MPC despite initial noninformative testing. It increased the number of PGVs detected in less established cancer predisposition genes, which include CFTR, SPINK1, TNFRSF13B, TET2, ADA, CDKN1C, CTNNA1, DDX41, HAX1, RECQL4 and MBD4. Conclusion: Patients with MPC were more likely to harbour a PGV. Extended testing improved PGV detection rates, particularly for less well-known cancer predisposition genes.

引用

页数：9

共 32 条

[31] A clinical and genetic analysis of multiple primary cancer referrals to genetics services [J].

Whitworth, James ;

Hoffman, Jon ;

Chapman, Cyril ;

Ong, Kai Ren ;

Lalloo, Fiona ;

Evans, D. Gareth ;

Maher, Eamonn R. .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2015, 23 (05) :581-587

[32] Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome [J].

Win, Aung Ko ;

Lindor, Noralane M. ;

Winship, Ingrid ;

Tucker, Katherine M. ;

Buchanan, Daniel D. ;

Young, Joanne P. ;

Rosty, Christophe ;

Leggett, Barbara ;

Giles, Graham G. ;

Goldblatt, Jack ;

Macrae, Finlay A. ;

Parry, Susan ;

Kalady, Matthew F. ;

Baron, John A. ;

Ahnen, Dennis J. ;

Le Marchand, Loic ;

Gallinger, Steven ;

Haile, Robert W. ;

Newcomb, Polly A. ;

Hopper, John L. ;

Jenkins, Mark A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (04) :274-279

← 1 2 3 4 →